Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking

PLoS Pathog. 2021 Apr 20;17(4):e1009434. doi: 10.1371/journal.ppat.1009434. eCollection 2021 Apr.

Abstract

The glycosphingolipid (GSL) globoside (Gb4) is essential for parvovirus B19 (B19V) infection. Historically considered the cellular receptor of B19V, the role of Gb4 and its interaction with B19V are controversial. In this study, we applied artificial viral particles, genetically modified cells, and specific competitors to address the interplay between the virus and the GSL. Our findings demonstrate that Gb4 is not involved in the binding or internalization process of the virus into permissive erythroid cells, a function that corresponds to the VP1u cognate receptor. However, Gb4 is essential at a post-internalization step before the delivery of the single-stranded viral DNA into the nucleus. In susceptible erythroid Gb4 knockout cells, incoming viruses were arrested in the endosomal compartment, showing no cytoplasmic spreading of capsids as observed in Gb4-expressing cells. Hemagglutination and binding assays revealed that pH acts as a switch to modulate the affinity between the virus and the GSL. Capsids interact with Gb4 exclusively under acidic conditions and dissociate at neutral pH. Inducing a specific Gb4-mediated attachment to permissive erythroid cells by acidification of the extracellular environment led to a non-infectious uptake of the virus, indicating that low pH-mediated binding to the GSL initiates active membrane processes resulting in vesicle formation. In summary, this study provides mechanistic insight into the interaction of B19V with Gb4. The strict pH-dependent binding to the ubiquitously expressed GSL prevents the redirection of the virus to nonpermissive tissues while promoting the interaction in acidic intracellular compartments as an essential step in infectious endocytic trafficking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Capsid / metabolism*
  • Capsid Proteins / drug effects
  • Capsid Proteins / metabolism
  • Endocytosis / immunology*
  • Endocytosis / physiology
  • Globosides / metabolism
  • Glycosphingolipids / metabolism*
  • Humans
  • Parvovirus B19, Human / genetics*
  • Parvovirus B19, Human / pathogenicity
  • Receptors, Virus / drug effects
  • Receptors, Virus / metabolism
  • Virion / drug effects
  • Virion / metabolism
  • Virus Internalization / drug effects

Substances

  • Capsid Proteins
  • Globosides
  • Glycosphingolipids
  • Receptors, Virus

Grants and funding

This study was supported by a grant from the Swiss National Science Foundation (grant 31003A_179384 to J.B.). www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.